drugset / Trial / NCT00310271

A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

NCT00310271 ↗

Phase 1 Completed 42 enrolled PowderMed
RandomizedFactorialDouble-blindTreatment

Summary

The purpose of this study is to evaluate how well the vaccine is tolerated at sites where administrations are given and any effects it may have on subjects' wellbeing. The study will also test the ability of vaccine to cause particular immune responses in the body.

Timeline

Start
2006-04
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject pPJV2012 Unknown — Other
Subject pPJV7630 Vaccine — Other